ReviewCureus2025
Exploring the Potential of Artificial Intelligence (AI) and Augmented Reality (AR) in Neurological Disease Management: A Narrative Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Digital Psychiatry with Virtual Reality and Augmented Reality: Recent Advances and Limitations.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advancements in artificial intelligence (AI) and augmented reality (AR) hold significant promise for revolutionizing the management of neurological diseases. These technologies enable enhanced diagnostic accuracy, personalized treatment plans, and innovative rehabilitation strategies. AI-driven systems can analyze complex neuroimaging data, track disease progression, and assist in neuroprosthetic interventions, while AR improves surgical precision and supports interactive, immersive training for healthcare professionals. This narrative review explores the current and potential applications of AI and AR in neurology, focusing on their impact on diagnosing and treating neurodegenerative disorders, stroke, and other neurological conditions. We also address the challenges of data security, bias in AI models, and the high cost of AR devices, along with the ethical implications of integrating these technologies into clinical practice. The review concludes with a discussion of future directions, emphasizing the need for larger, long-term studies, interdisciplinary collaborations, and policy frameworks to ensure the safe, equitable, and effective implementation of AI and AR in neurological care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.